# FDA Inspection 1113161 - Biomat USA Inc - December 05, 2019

Source: https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/f82eb689-dc32-46a9-9c26-5208f78219f9
Source feed: FDA_Inspections

> FDA Inspection 1113161 for Biomat USA Inc on December 05, 2019. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1113161
- Company Name: Biomat USA Inc
- Inspection Date: 2019-12-05
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1010370 - 2017-04-20](https://www.keypedia.com/records/fda_inspections/biomat-usa-inc/c56612ac-d2bc-4fcd-803f-f53212c656b0)

Company: https://www.keypedia.com/companies/biomat-usa-inc/b4537d2b-1fd7-4683-b945-3d3f678a9b59

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d